ARMISTICE CAPITAL, LLC - Q2 2021 holdings

$5.59 Billion is the total value of ARMISTICE CAPITAL, LLC's 116 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .

 Value Shares↓ Weighting
AUUDW ExitAUDDIA INC*w exp 10/17/202$0-30,400
-100.0%
0.00%
CUENW ExitCUENTAS INC*w exp 99/99/999$0-50,000
-100.0%
-0.00%
RZLT ExitREZOLUTE INC$0-288,000
-100.0%
-0.05%
PBPB ExitPOTBELLY CORP$0-407,099
-100.0%
-0.06%
ExitPREDICTIVE ONCOLOGY INC$0-2,051,284
-100.0%
-0.06%
FTEK ExitFUEL TECH INC$0-850,000
-100.0%
-0.06%
ExitOBALON THERAPEUTICS INC$0-1,100,000
-100.0%
-0.07%
PRFX ExitPAINREFORM LTD$0-839,346
-100.0%
-0.08%
HOTH ExitHOTH THERAPEUTICS INC$0-2,270,000
-100.0%
-0.10%
RWLK ExitREWALK ROBOTICS LTD$0-1,911,264
-100.0%
-0.11%
PLAN ExitANAPLAN INC$0-132,000
-100.0%
-0.16%
DT ExitDYNATRACE INC$0-150,000
-100.0%
-0.17%
ALT ExitALTIMMUNE INC$0-536,000
-100.0%
-0.17%
SILK ExitSILK RD MED INC$0-150,000
-100.0%
-0.17%
EGRX ExitEAGLE PHARMACEUTICALS INC$0-192,000
-100.0%
-0.18%
WDAY ExitWORKDAY INCcl a$0-35,000
-100.0%
-0.20%
TNDM ExitTANDEM DIABETES CARE INC$0-100,000
-100.0%
-0.20%
BGS ExitB & G FOODS INC NEW$0-288,000
-100.0%
-0.20%
AEO ExitAMERICAN EAGLE OUTFITTERS IN$0-387,995
-100.0%
-0.26%
UAA ExitUNDER ARMOUR INCcl a$0-566,881
-100.0%
-0.29%
POOL ExitPOOL CORP$0-36,875
-100.0%
-0.29%
FIVE ExitFIVE BELOW INC$0-66,800
-100.0%
-0.29%
GPS ExitGAP INC$0-515,617
-100.0%
-0.35%
AVTR ExitAVANTOR INC$0-636,000
-100.0%
-0.42%
POST ExitPOST HLDGS INC$0-188,000
-100.0%
-0.46%
TSCO ExitTRACTOR SUPPLY CO$0-132,737
-100.0%
-0.54%
ADBE ExitADOBE SYSTEMS INCORPORATED$0-54,000
-100.0%
-0.59%
RL ExitRALPH LAUREN CORPcl a$0-290,517
-100.0%
-0.82%
NKE ExitNIKE INCcl b$0-322,491
-100.0%
-0.98%
AAP ExitADVANCE AUTO PARTS INC$0-273,469
-100.0%
-1.15%
LNTH ExitLANTHEUS HLDGS INC$0-2,700,000
-100.0%
-1.32%
TJX ExitTJX COS INC NEW$0-1,128,122
-100.0%
-1.71%
IWM ExitISHARES TRput$0-2,000,000
-100.0%
-10.14%
SPY ExitSPDR S&P 500 ETF TRput$0-2,000,000
-100.0%
-18.20%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ENANTA PHARMACEUTICALS INC30Q3 20232.7%
SPDR S&P 500 ETF TR28Q3 202329.5%
MADRIGAL PHARMACEUTICALS INC27Q3 20232.9%
VANDA PHARMACEUTICALS INC26Q3 20219.4%
REGENERON PHARMACEUTICALS25Q3 20233.2%
ENERGIZER HLDGS INC NEW22Q2 20233.7%
ANTARES PHARMA INC21Q3 20206.6%
INCYTE CORP21Q3 20232.8%
VOYAGER THERAPEUTICS INC21Q3 20232.0%
BLUEBIRD BIO INC20Q4 20211.8%

View ARMISTICE CAPITAL, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
ARMISTICE CAPITAL, LLC Q2 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Avalo Therapeutics, Inc.June 28, 2023588,8504.7%
Addex Therapeutics Ltd.February 16, 2023675,2955.0%
Arcadia Biosciences, Inc.February 14, 20232,675,40910.0%
Avinger IncFebruary 14, 2023789,40010.0%
Baudax Bio, Inc.February 14, 20231,165,7095.0%
BIORA THERAPEUTICS, INC.February 14, 202312,989,6485.7%
Bit Digital, IncFebruary 14, 20233,161,8893.7%
Bruush Oral Care Inc.February 14, 20231,122,92210.0%
CATALYST PHARMACEUTICALS, INC.Sold outFebruary 14, 202300.0%
Clarus Therapeutics Holdings, Inc.February 14, 20232,732,1695.0%

View ARMISTICE CAPITAL, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View ARMISTICE CAPITAL, LLC's complete filings history.

Compare quarters

Export ARMISTICE CAPITAL, LLC's holdings